Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 2

1(11.1%)

9Total

N/A(8)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT05439135Not ApplicableRecruiting

Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract

Role: collaborator

NCT06392646Not ApplicableActive Not Recruiting

The Effect of a Postoperative Education Programme Based on Swanson's Theory of Caring on the Self-management Behavioural Competence of Elderly Enterostomal Patients

Role: lead

NCT05975398Unknown

China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）

Role: collaborator

NCT05804474Completed

A Retrospective, Multicenter, Controlled Clinical Trail: to Evaluate the Clinical Efficiency of Intracranial Aneurysm Assistive Software in the Morphological Measurement

Role: collaborator

NCT03541733Not ApplicableCompleted

Bowel Preparation for Magnetic Resonance Enterography

Role: collaborator

NCT05322330Phase 2Unknown

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Role: collaborator

NCT04909528Not ApplicableUnknown

LLTS to Treat Premature Ventricular Contractions

Role: collaborator

NCT05253222Not ApplicableUnknown

Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET